Krystal Biotech buy Chardan Capital
Start price
05.08.25
/
50%
€118.80
Target price
05.08.26
€189.46
Performance (%)
18.01%
Price
22.09.25
€140.20
Summary
This prediction is currently active. The prediction currently has a performance of 18.01%. This prediction currently runs until 05.08.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 5.851% | 5.851% |
| iShares Core DAX® | -0.560% | -3.108% |
| iShares Nasdaq 100 | 1.622% | 4.701% |
| iShares Nikkei 225® | 1.807% | 5.094% |
| iShares S&P 500 | 0.859% | 2.906% |
Comments by Chardan_Capital for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $219.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Chardan_Capital for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€127.05
22.08.25
22.08.25
€186.08
22.08.26
22.08.26
10.35%
22.09.25
22.09.25
Krystal Biotech
Start price
Target price
Perf. (%)
€125.75
25.07.25
25.07.25
€186.52
25.07.26
25.07.26
11.49%
22.09.25
22.09.25
Krystal Biotech
Start price
Target price
Perf. (%)
€116.70
07.05.25
07.05.25
€193.05
07.05.26
07.05.26
20.14%
22.09.25
22.09.25
Krystal Biotech
Start price
Target price
Perf. (%)
€172.25
20.02.25
20.02.25
€208.60
20.02.26
20.02.26
-18.61%
22.09.25
22.09.25
Krystal Biotech
Start price
Target price
Perf. (%)
€151.90
18.12.24
18.12.24
€202.14
18.12.25
18.12.25
-7.70%
22.09.25
22.09.25
Krystal Biotech
Start price
Target price
Perf. (%)
€165.85
12.12.24
12.12.24
€201.99
12.12.25
12.12.25
-15.47%
22.09.25
22.09.25